Lv11
74 积分 2024-10-21 加入
Bemarituzumab in patients with FGFR2b-selected gastric or gastro-oesophageal junction adenocarcinoma (FIGHT): a randomised, double-blind, placebo-controlled, phase 2 study
2小时前
已完结
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
27天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
1个月前
已完结
皖公网安备34019202002308
